Zepto Life Technology Email Format
Biotechnology ResearchMinnesota, United States11-50 Employees
Zepto Life Technology is a biotechnology research company based in St. Paul, Minnesota, focused on molecular diagnostics for life-threatening infections. The company seeks to deliver rapid, accurate, multiplexed diagnostic tools with straightforward use to improve diagnosis and reduce reliance on traditional culture methods. Its work centers on developing a broad pathogen panel using Giant Magnetoresistance technology, complemented by in-house diagnostic laboratories and contract research organization services to support other firms in bringing tests to market. In January 2026, Zepto Life launched the FungiFlex Mold Panel, a plasma-based molecular test offered through its CLIA-certified reference laboratory to provide faster, noninvasive testing for patients at risk of invasive fungal infections. The firm also expanded its scientific leadership with the addition of Dr. David S. Perlin to its Advisory Board.